134 related articles for article (PubMed ID: 19184288)
1. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute.
Yamada N; Uchinuma E; Matsumoto Y; Kuroyanagi Y
J Artif Organs; 2008; 11(4):221-4. PubMed ID: 19184288
[TBL] [Abstract][Full Text] [Related]
2. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
Sawa M; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
[TBL] [Abstract][Full Text] [Related]
3. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.
Kubo K; Kuroyanagi Y
Artif Organs; 2004 Feb; 28(2):182-8. PubMed ID: 14961958
[TBL] [Abstract][Full Text] [Related]
4. A study of cytokines released from fibroblasts in cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):845-9. PubMed ID: 16185348
[TBL] [Abstract][Full Text] [Related]
5. The possibility of long-term cryopreservation of cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):800-5. PubMed ID: 16185341
[TBL] [Abstract][Full Text] [Related]
6. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
Kubo K; Kuroyanagi Y
J Biomater Sci Polym Ed; 2003; 14(7):625-41. PubMed ID: 12903732
[TBL] [Abstract][Full Text] [Related]
7. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(2):138-44. PubMed ID: 14598115
[TBL] [Abstract][Full Text] [Related]
9. Establishment of banking system for allogeneic cultured dermal substitute.
Kuroyanagi Y; Kubo K; Matsui H; Kim HJ; Numari S; Mabuchi Y; Kagawa S
Artif Organs; 2004 Jan; 28(1):13-21. PubMed ID: 14720283
[TBL] [Abstract][Full Text] [Related]
10. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(4):267-72. PubMed ID: 14691669
[TBL] [Abstract][Full Text] [Related]
11. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix.
Yamada N; Uchinuma E; Kuroyanagi Y
Scand J Plast Reconstr Surg Hand Surg; 1999 Jun; 33(2):147-54. PubMed ID: 10450570
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
Tanaka M; Nakakita N; Kuroyanagi Y
J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
[TBL] [Abstract][Full Text] [Related]
14. Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.
Hashimoto A; Kuroyanagi Y
J Artif Organs; 2008; 11(4):225-31. PubMed ID: 19184289
[TBL] [Abstract][Full Text] [Related]
15. Application of cultured dermal substitute for amelioration of maxillary bone growth suppression after cleft palate operation in rats.
Kurokawa N; Ueda K; Tsuji M; Kuroyanagi Y
J Artif Organs; 2008; 11(4):216-20. PubMed ID: 19184287
[TBL] [Abstract][Full Text] [Related]
16. [Advances in regenerative medicine for skin].
Kuroyanagi Y
Nihon Ronen Igakkai Zasshi; 2005 Nov; 42(6):609-15. PubMed ID: 16408496
[TBL] [Abstract][Full Text] [Related]
17. Design of a matrix for cultured dermal substitute suitable for simultaneous transplantation with auto-skin graft: evaluation in animal test.
Matsumoto Y; Kuroyanagi Y
J Biomater Sci Polym Ed; 2010; 21(1):83-94. PubMed ID: 20040155
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
[TBL] [Abstract][Full Text] [Related]
19. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.
Hasegawa T; Suga Y; Mizoguchi M; Muramatsu S; Mizuno Y; Ogawa H; Kubo K; Kuroyanagi Y
J Dermatol; 2005 Sep; 32(9):715-20. PubMed ID: 16361714
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing.
Yamada N; Shioya N; Kuroyanagi Y
Scand J Plast Reconstr Surg Hand Surg; 1995 Sep; 29(3):211-9. PubMed ID: 8539563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
